G1 Therapeutics Inc (GTHX)
$1.27
0.07 (5.22%)
Why Is G1 Therapeutics (GTHX) Stock Down 52% Today?
G1 Therapeutics (GTHX) stock is falling on Monday after the company announced plans to discontinue a Phase 3 clinical trial.
11 Best Stocks to Buy for 2023

INSIDE: Investing legend Louis Navellier reveals his Top 11 Stocks for 2023 — FREE!
Download His Free Report Here:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
54.24M
PE Ratio
-0.74
EPS
-1.71
Volume (Avg. Vol.)
455,085
Day's Range
$1.27 - $1.33
52-Week Range
$1.27 - $14.46
Dividend & Yield
N/A (N/A)